Abstract
Neuroleptic malignant syndrome and malignant hyperthermia share two cardinal clinical features: hypothermia and rigidity. Both syndromes can result in rhabdomyolysis and have high mortality rates if left untreated. This article reviews each syndrome and its pathogenesis and treatment.
MeSH terms
-
Dantrolene / therapeutic use
-
Diagnosis, Differential
-
Dopamine Agents / therapeutic use
-
Humans
-
Malignant Hyperthermia* / diagnosis
-
Malignant Hyperthermia* / drug therapy
-
Malignant Hyperthermia* / etiology
-
Neuroleptic Malignant Syndrome* / diagnosis
-
Neuroleptic Malignant Syndrome* / drug therapy
-
Neuroleptic Malignant Syndrome* / etiology
-
Referral and Consultation
Substances
-
Dopamine Agents
-
Dantrolene